These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 28610835)
41. Lavage with allicin in combination with vancomycin inhibits biofilm formation by Staphylococcus epidermidis in a rabbit model of prosthetic joint infection. Zhai H; Pan J; Pang E; Bai B PLoS One; 2014; 9(7):e102760. PubMed ID: 25025650 [TBL] [Abstract][Full Text] [Related]
42. Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms. Presterl E; Hajdu S; Lassnigg AM; Hirschl AM; Holinka J; Graninger W Antimicrob Agents Chemother; 2009 Aug; 53(8):3205-10. PubMed ID: 19451280 [TBL] [Abstract][Full Text] [Related]
43. Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. Balaban N; Giacometti A; Cirioni O; Gov Y; Ghiselli R; Mocchegiani F; Viticchi C; Del Prete MS; Saba V; Scalise G; Dell'Acqua G J Infect Dis; 2003 Feb; 187(4):625-30. PubMed ID: 12599079 [TBL] [Abstract][Full Text] [Related]
44. Activity of bone cement loaded with daptomycin alone or in combination with gentamicin or PEG600 against Staphylococcus epidermidis biofilms. Peñalba Arias P; Furustrand Tafin U; Bétrisey B; Vogt S; Trampuz A; Borens O Injury; 2015 Feb; 46(2):249-53. PubMed ID: 25498330 [TBL] [Abstract][Full Text] [Related]
45. Sub-inhibitory tigecycline concentrations induce extracellular matrix binding protein Embp dependent Staphylococcus epidermidis biofilm formation and immune evasion. Weiser J; Henke HA; Hector N; Both A; Christner M; Büttner H; Kaplan JB; Rohde H Int J Med Microbiol; 2016 Sep; 306(6):471-8. PubMed ID: 27292911 [TBL] [Abstract][Full Text] [Related]
47. Low concentrations of vancomycin stimulate biofilm formation in some clinical isolates of Staphylococcus epidermidis. Cargill JS; Upton M J Clin Pathol; 2009 Dec; 62(12):1112-6. PubMed ID: 19640858 [TBL] [Abstract][Full Text] [Related]
48. The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus. Tan H; Peng Z; Li Q; Xu X; Guo S; Tang T Biomaterials; 2012 Jan; 33(2):365-77. PubMed ID: 22014946 [TBL] [Abstract][Full Text] [Related]
49. Polysaccharide intercellular adhesin in biofilm: structural and regulatory aspects. Arciola CR; Campoccia D; Ravaioli S; Montanaro L Front Cell Infect Microbiol; 2015; 5():7. PubMed ID: 25713785 [TBL] [Abstract][Full Text] [Related]
50. The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection. Antoci V; Adams CS; Parvizi J; Davidson HM; Composto RJ; Freeman TA; Wickstrom E; Ducheyne P; Jungkind D; Shapiro IM; Hickok NJ Biomaterials; 2008 Dec; 29(35):4684-90. PubMed ID: 18814909 [TBL] [Abstract][Full Text] [Related]
51. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. Singh R; Ray P; Das A; Sharma M J Antimicrob Chemother; 2010 Sep; 65(9):1955-8. PubMed ID: 20615927 [TBL] [Abstract][Full Text] [Related]
52. Densely adherent growth mode, rather than extracellular polymer substance matrix build-up ability, contributes to high resistance of Staphylococcus epidermidis biofilms to antibiotics. Qu Y; Daley AJ; Istivan TS; Rouch DA; Deighton MA J Antimicrob Chemother; 2010 Jul; 65(7):1405-11. PubMed ID: 20430788 [TBL] [Abstract][Full Text] [Related]
53. Pentadecanal inspired molecules as new anti-biofilm agents against Staphylococcus epidermidis. Ricciardelli A; Casillo A; Papa R; Monti DM; Imbimbo P; Vrenna G; Artini M; Selan L; Corsaro MM; Tutino ML; Parrilli E Biofouling; 2018 Nov; 34(10):1110-1120. PubMed ID: 30698031 [TBL] [Abstract][Full Text] [Related]
54. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains. Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759 [TBL] [Abstract][Full Text] [Related]
55. Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin. Leitch EC; Willcox MD Curr Eye Res; 1999 Jul; 19(1):12-9. PubMed ID: 10415452 [TBL] [Abstract][Full Text] [Related]
56. Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis. Monzón M; Oteiza C; Leiva J; Amorena B J Antimicrob Chemother; 2001 Dec; 48(6):793-801. PubMed ID: 11733463 [TBL] [Abstract][Full Text] [Related]
57. Potency and penetration of telavancin in staphylococcal biofilms. Kirker KR; Fisher ST; James GA Int J Antimicrob Agents; 2015 Oct; 46(4):451-5. PubMed ID: 26213381 [TBL] [Abstract][Full Text] [Related]
58. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms. Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828 [TBL] [Abstract][Full Text] [Related]
59. Evaluation of MBEC™-HTP biofilm model for studies of implant associated infections. Coraça-Hubér DC; Fille M; Hausdorfer J; Pfaller K; Nogler M J Orthop Res; 2012 Jul; 30(7):1176-80. PubMed ID: 22228044 [TBL] [Abstract][Full Text] [Related]
60. Antimicrobial peptides: an effective approach to prevent bacterial biofilm formation in platelet concentrates. Alabdullatif M; Atreya CD; Ramirez-Arcos S Transfusion; 2018 Aug; 58(8):2013-2021. PubMed ID: 29687885 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]